Then, the mice bearing BCPAP tumor were injected via tail vein with Lipo MBs and Gal-3-C12@lipo MBs, respectively, and the contrast-enhanced ultrasound imaging of tumor was monitored during the entire injection process. This evidence concerns the gene LGALS3 and neoplasm.